Skip to main content
Equibles

Glendon French

CEO

Pulmonx Corp (LUNG)

Board Member

Pulmonx Corp (LUNG)

Equibles does not estimate personal net worth.

Get an email with a short summary when Pulmonx Corp publishes a filing, an earnings call transcript or a press release.

Get LUNG alerts

About Glendon French

Glendon French is recorded as CEO and Board Member at Pulmonx Corp (LUNG). The proxy statement of Pulmonx Corp reports total compensation of $3,543,520 for Glendon French in fiscal 2025, including a base salary of $116,186. Disclosed compensation is on record for 7 fiscal years. Glendon French has spoken on 5 earnings calls and 2 other investor events across 1 company, most recently for Pulmonx Corp on August 11, 2026. Pulmonx Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Pulmonx Corp includes Glendon E. French (CEO and Board Member), Steven S. Williamson (CEO and Board Member), Derrick Sung (CFO and COO) and 4 others.

Glendon French on recent calls

“Well, we've filled all of our sales leadership openings that we had. We had a significant amount of turnover last year in our sales organization, So that was the first level thing that we needed to do.”
CEO, Canaccord Genuity 46th Annual Growth Conference ·
“So just by way of background, I've been in the interventional pulmonology space for about 30 years, 10 years with Pulmonix, came to a turnaround challenge. We turned the business around, took the company public in 2020, and I retired in 2024.”
CEO, Bank of America Securities 2026 Health Care Conference ·
“Good afternoon, everyone, and welcome to our fourth quarter and full year 2025 earnings call. Since returning as CEO, I've conducted a thorough review of our business, and I am both confident in the company's future and determined to accelerate its progress.”
CEO, Pulmonx Q4 2025 Earnings Conference Call ·
“Good afternoon, everyone, and welcome to our fourth quarter and full year 2023 earnings call. Here with me is John McKune, our Interim Chief Financial Officer.”
CEO, Pulmonx Corp Q4 FY2023 Earnings Call ·
“Here with me is John McKune, our recently appointed Interim Chief Financial Officer, who's been a leader on our finance team as VP Corporate Controller since our IPO.”
CEO, Pulmonx Corp Q3 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at Pulmonx Corp

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Pulmonx Corp (LUNG) $116,186 $3,543,520
2024 Pulmonx Corp (LUNG) $195,564 $330,786
2023 Pulmonx Corp (LUNG) $580,000 $5,795,297
2022 Pulmonx Corp (LUNG) $569,000 $4,565,019
2021 Pulmonx Corp (LUNG) $550,000 $4,812,494
2020 Pulmonx Corp (LUNG) $442,803 $3,373,436
2019 Pulmonx Corp (LUNG) $412,000 $1,122,487

Recent activity